MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences ROE Ratio 2011-2026 | ANIX
Annual ROE Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.07 | -62.78 | -40.31 | -46.8 | -36.55 | -122.12 | -242.02 | -270.01 | -63.22 | -508.01 | -27.29 | -239.58 | 303.56 | 356.16 | -697.34 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 356.16 | -697.34 | -117.89 |
Quarterly ROE Ratio Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61.59 | -50.02 | -65.86 | -68.09 | -64.63 | -42.97 | -53.18 | -47.56 | -42.49 | -27.67 | -62.51 | -61.18 | -63.63 | -71.24 | -61.63 | -64.84 | -60.32 | -91.7 | -155.44 | -172.59 | -195.95 | -238.98 | -332.61 | -344.25 | -363.3 | -301.22 | -281.49 | -341.39 | -317.57 | -194.78 | -72.6 | 5.53 | 32.92 | -105.67 | -466.89 | -556.02 | -686.85 | -597.05 | -196.85 | -116.78 | -32.24 | -13.92 | -173.15 | -131.19 | -167.98 | -73.5 | 302.86 | 370.37 | 525.99 | 247.68 | 188.07 | 163.01 | 161.88 | 18.13 | -401.51 | -621.82 | -553.09 | -263.83 | -167.62 | -121.64 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 525.99 | -686.85 | -130.07 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CareDx, Inc
CDNA
|
-7.05 | $ 20.85 | 0.24 % | $ 1.11 B |  USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.58 | 3.27 % | $ 2.1 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 17.24 | 6.16 % | $ 176 M |  China |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 114.05 | 2.47 % | $ 34.7 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 115.8 | -0.32 % | $ 9.55 B |  Irlanda |
 |
Illumina
ILMN
|
-51.54 | $ 126.0 | 4.67 % | $ 20 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 82.59 | 1.74 % | $ 5.57 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 420.1 | 1.57 % | $ 12.1 B | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 16.14 | -2.42 % | $ 361 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 26.22 | 2.48 % | $ 20 B |  Niderland |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 15.12 | 2.16 % | $ 457 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.4 | -0.43 % | $ 267 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.42 | 0.74 % | $ 678 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 474.87 | 1.78 % | $ 179 B | USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.62 | 3.33 % | $ 61.9 M | Irlanda |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 58.67 | 3.47 % | $ 3.51 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 164.71 | 0.53 % | $ 8.16 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 83.76 | 0.42 % | $ 10.5 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.04 | 0.89 % | $ 1.16 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 5.18 | 2.78 % | $ 307 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 1.99 | - | $ 8.8 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-121.14 | $ 2.16 | -0.15 % | $ 4.96 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 260.19 | 1.19 % | $ 21.6 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 120.5 | 1.26 % | $ 5.63 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.34 | 3.61 % | $ 2.03 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.8 | 2.46 % | $ 444 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
-77.62 | $ 200.6 | 3.0 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 193.47 | 2.19 % | $ 21.5 B | USA |